Patents by Inventor Bjorn Nilsson

Bjorn Nilsson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030092694
    Abstract: The invention relates to compounds of the general formula (I): 1
    Type: Application
    Filed: October 11, 2002
    Publication date: May 15, 2003
    Applicant: Biovitrum, AB, a Stockholm, Sweden corporation
    Inventors: Bjorn Nilsson, Jan Tejbrant, Benjamin Pelcman, Erik Ringberg, Markus Thor, Jonas Nilsson, Mattias Jonsson
  • Patent number: 6534628
    Abstract: Novel proteins obtainable by mutagenesis of surface-exposed amino acids of domains of natural bacterial receptors, said proteins being obtained without substantial loss of basic structure and stability of said natural bacterial receptors; proteins which have been selected from a protein library embodying a repertoire of said novel proteins; and methods for the manufacture of artificial bacterial receptor structures.
    Type: Grant
    Filed: May 21, 1998
    Date of Patent: March 18, 2003
    Assignee: Biovitrum AB
    Inventors: Björn Nilsson, Per-Åke Nygren, Mathias Uhlén
  • Patent number: 6465467
    Abstract: Compounds of the general formula (I): wherein the variables are as defined in the specification are useful for the prophylaxis or treatment of serotonin-related, especially 5-HT2 receptor-related, diseases in human beings or animals, particularly diseases related to the 5-HT2c receptor, especially diseases such as eating disorders, memory disorders, schizophrenia, mood disorders, anxiety disorders, pain, sexual dysfunctionions, and urinary disorders.
    Type: Grant
    Filed: June 8, 2000
    Date of Patent: October 15, 2002
    Assignee: Biovitrum AB
    Inventors: Björn Nilsson, Jan Tejbrant, Benjamin Pelcman, Erik Ringberg, Markus Thor, Jonas Nilsson, Mattias Jönsson
  • Patent number: 5876968
    Abstract: Substantially pure dimers of Apolipoprotein Al-Milano (Al-M/APO Al-M) isolated and characterized from plasma are provided. Pharmaceutical compositions comprising the Apo Al-M/Apo Al-M are also provided. Apolipoprotein Al-M dimer can be produced in a recombinant Escherichia coli system or collected from plasma from Apolipoprotein Al-Milano carriers. Atherosclerosis and cardiovascular diseases can be treated with the dimer. Medicaments containing the dimer can also be used for preventing thrombosis in different clinical circumstances, both at the arterial and at the venous level. The dimer can also act as a prodrug for the monomer.
    Type: Grant
    Filed: November 4, 1993
    Date of Patent: March 2, 1999
    Assignee: Pharmacia & Upjohn Aktiebolag
    Inventors: Cesare Sirtori, Guido Franceschini, Lars Abrahmsen, Erik Holmgren, Mats Lake, Bjorn Nilsson, Joanna Chmielewska, Peter Lind
  • Patent number: 5831012
    Abstract: Novel proteins obtainable by mutagenesis of surface-exposed amino acids of domains of natural bacterial receptors, said proteins being obtained without substantial loss of basic structure and stability of said natural bacterial receptors; proteins which have been selected from a protein library embodying a repertoire of said novel proteins; and methods for the manufacture of artificial bacterial receptor structures.
    Type: Grant
    Filed: August 15, 1996
    Date of Patent: November 3, 1998
    Assignee: Pharmacia & Upjohn Aktiebolag
    Inventors: Bjorn Nilsson, Per-.ANG.ke Nygren, Mathias Uhlen
  • Patent number: 5745775
    Abstract: A method is provided for displaying prices of articles on display units adjacent to the location of the articles at a point of sale. The method is useful in operating a number of detached display units, which reproduce information, which is changeable by a wireless communication from a central computer or a portable terminal. A problem related to information systems of this type consists in easily and conveniently providing for assigning an identification code corresponding to a particular article to a display unit. According to the method described herein, this is achieved by a control unit, integrated within the display unit, and being able to be set by an external switch or signal, the control unit in such set state being arranged to receive and to store an identification code transmitted from the portable terminal.
    Type: Grant
    Filed: June 9, 1997
    Date of Patent: April 28, 1998
    Assignee: Pricer Inc.
    Inventors: Roger Ahlm, Ola Odmark, Bjorn Nilsson
  • Patent number: 5683980
    Abstract: Processes for refolding of insulin-like growth factor (IGF) comprise contacting IGF in a reduced or misfolded form with insulin-like growth factor binding protein (IGF-BP), and recovering native IGF.
    Type: Grant
    Filed: August 5, 1996
    Date of Patent: November 4, 1997
    Assignee: Pharmacia & Upjohn AB
    Inventors: Bjorn Nilsson, Sophia Elisabeth Hober
  • Patent number: 5579009
    Abstract: A sensor system comprises a plurality of sensor stations of the same type for surveillance of an area intended to include an object to be protected, the sensor stations being distributed essentially along the periphery of a circle, in the central part of which an object to be protected is intended to be contained. Each sensor station includes a detector unit which is arranged to scan an arc in an azimuth sector of the circle allocated to it up towards the background of the sky in each of two detection fields formed along the arc having different elevation angles with respect to the detector unit. The time of the passage of a target between the two detection fields is measured, and the target position is calculated relative to the sensor station on the basis of the measured time, the speed of the target, the angle between the detection fields and the angle to the target.
    Type: Grant
    Filed: September 22, 1994
    Date of Patent: November 26, 1996
    Assignee: Bofors AB
    Inventors: Bo Nilsson-Almqvist, Bjorn Nilsson
  • Patent number: 5411732
    Abstract: A process for preparing antibodies specific for an amino acid sequence which comprises immunizing a mammal with a fused protein comprising said amino acid sequence fused to an immunogenic IgG binding protein is disclosed.
    Type: Grant
    Filed: October 1, 1993
    Date of Patent: May 2, 1995
    Assignee: Kabi Pharmacia Aktiebolag
    Inventors: Bjorn Lowenadler, Erik Holmgren, Mathias Uhlen, Bjorn Nilsson
  • Patent number: 5156959
    Abstract: A process for expressing proteins in Gram(-) bacteria and providing for extracellular secretion thereof, comprising the steps: a) introducing into a Gram(-) bacterium a recombinant DNA construction comprising a promoter, a signal sequence enabling translocation and processing, and a structural gene encoding the desired protein to be expressed; b) cultivating the bacterium under conditions resulting in filamentous growth; and c) recovering the extracellularly secreted protein; a recombinant DNA construction comprising:a promoter, a signal sequence and a structural gene including a cleavage region,wherein the structural gene is of the formula:(E).sub.n (B).sub.m -Y,where n is an integer .gtoreq.
    Type: Grant
    Filed: October 24, 1990
    Date of Patent: October 20, 1992
    Assignee: KabiGen AB
    Inventors: Lars Abrahmsen, Tomas Moks, Bjorn Nilsson, Mathias Uhlen
  • Patent number: 5143844
    Abstract: A recombinant DNA fragment (Z) coding for an immunoglobulin G binding domain related to staphylococcal protein A. The methionine codon of the recombinant DNA fragment has been replaced with a codon of an amino acid residue other than methionine to enable expression of a methionine-free protein. The present invention is also directed to recombinant DNA sequence containing such recombinant DNAS fragment (Z) as well as a recombinant DNA molecule, plasmid vector and bacterial cell containing such recombinant DNAS fragment. Also disclosed is a process for cleaving a fused protein expressed in a biological system using said recombinant DNA fragment.
    Type: Grant
    Filed: October 9, 1990
    Date of Patent: September 1, 1992
    Assignee: KabiGen AB
    Inventors: Lars Abrahmsen, Tomas Moks, Bjorn Nilsson, Mathias Uhlen